Graphic illustrating the e-TLIF procedure

Treat Neuropathic Pain at the Same Spinal Level as the Spine Surgery
Our Ultra Low Energy (ULE™) Therapy utilizes SynerFuse® procedure, Electric Transforaminal Lumbar Interbody Fusion (e-TLIF™), is a direct nerve stimulation at the same spinal level as the spinal fusion procedure for optimal patient outcomes.

Our Technology

The SynerFuse® e-TLIF™ procedure incorporates input from the company’s medical team of surgeons and learnings from our completed proof-of-concept (POC) study. This enables our NeuroFuse® System to provide Ultra Low Energy (ULE) therapy for direct nerve stimulation at the point of spine fusion. The NeuroFuse® System consists of an implantable pulse generator (“IPG”), a multi-channel lead to deliver electrical impulses from the IPG to the spine, and a mobile device application to enable individualized programming of the IPG. Plus a clinician programmer to allow for remote programming and monitoring of the patient via WIFI.

  • Patient-Focused Integrated Solution
    With our patented SynerFuse® e-TLIF™ procedure, we hope to help people live without pain by making traditional spine implant surgery more successful and cost effective by combining neuromodulation at the time surgeons are performing fusion back surgery.

  • Surgeon-Centric
    Treat Neuropathic Pain at the Same Spinal Level as the Spine Surgery with single incision to maximize surgeon outcomes. Stim designed for surgeons.

  • Fusion Hardware-Agnostic
    Add-on to any fusion hardware that surgeons prefer.

Broad Patent Coverage to Enable Novel Innovation
SynerFuse® has 12 patents issued including the United States, Canada, and Australia. The SynerFuse® IP strategy protects key aspects of our concept and technology across the globe to enable our novel approach to solving chronic back pain.

World map with North America and Australia highlighted in blue.
SynerUse logo with a blue circular emblem and the text 'SynerUse' in blue, accompanied by the slogan 'Better Outcomes | Improved Lives'.